Two groups presented data supporting the utility of ctDNA in detecting the EGFR resistant mutation T790M even after SCLC transformation, uncovering the spatial heterogeneity of the tumor [72,73], while one group described the disappearance of acquired G1202R ALK mutation, concurrent with SCLC transformation [74]. The gene discussed is EGFR; the disease is small cell lung carcinoma.